Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Bleeding predictors in factor-XI-deficient patients
B Brenner, A Laor, H Lupo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 4, 2001
Atypical tinea corporis caused by Microsporum gypseum in a subject with acquired immune deficiency syndrome
A G Luque, M S Biasoli, M A Sortino, et al.
Blood
|
November 5, 1997
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin
H Peretz, A Mulai, S Usher, et al.
AIDS Research and Human Retroviruses
|
September 10, 2011
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial
Aimee Wilkin, Anton L Pozniak, Javier Morales-Ramirez, et al.
AIDS (London, England)
|
November 21, 2009
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
Anton L Pozniak, Javier Morales-Ramirez, Elly Katabira, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
March 10, 1998
Bleeding predictors in factor-XI-deficient patients
B Brenner, A Laor, H Lupo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 4, 2001
Atypical tinea corporis caused by Microsporum gypseum in a subject with acquired immune deficiency syndrome
A G Luque, M S Biasoli, M A Sortino, et al.
Blood
|
November 5, 1997
The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin
H Peretz, A Mulai, S Usher, et al.
AIDS Research and Human Retroviruses
|
September 10, 2011
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial
Aimee Wilkin, Anton L Pozniak, Javier Morales-Ramirez, et al.
AIDS (London, England)
|
November 21, 2009
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
Anton L Pozniak, Javier Morales-Ramirez, Elly Katabira, et al.
Page
of 1